A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients Article

sustainable development goals

publication date

  • February 14, 2017

webpage

published in

keywords

  • CHK1
  • LY2603618
  • cancer
  • gemcitabine
  • phase II

volume

  • 17